Glucagon-like peptide-1 (GLP-1) from intestinal L-cells stimulates insulin secretion and reduces appetite after food ingestion, and it is the basis for drugs against type-2 diabetes and obesity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.